Table 2.
n | LH∗ | FSH∗∗ | Estradiol | Testosterone | fT4∗∗∗ | TSH∗∗∗∗ | ||
---|---|---|---|---|---|---|---|---|
(IU L−1) | (IU L−1) | (nmol L−1) | (nmol L−1) | (pmol L−1) | (mIU L−1) | |||
Maca |
0 weeks | 11 | 4.03 ± 0.50 | 4.40 ± 0.37 | 0.10 ± 0.01 | 19.92 ± 1.75 | 16.31 ± 0.29 | 2.35 ± 0.30 |
12 weeks | 11 | 2.90 ± 0.33 | 3.75 ± 0.37 | 0.10 ± 0.01 | 20.10 ± 2.24 | 16.91 ± 0.62 | 1.58 ± 0.23 | |
P value | 0.09 | 0.23 | 0.76 | 0.88 | 0.95 | 0.07 | ||
| ||||||||
Placebo |
0 weeks | 7 | 3.82 ± 0.50 | 4.46 ± 0.50 | 0.09 ± 0.01 | 19.43 ± 2.25 | 14.02 ± 0.68 | 2.92 ± 1.63 |
12 weeks | 7 | 2.99 ± 0.57 | 3.55 ± 0.64 | 0.11 ± 0.01 | 18.63 ± 2.15 | 15.28 ± 0.72 | 2.63 ± 1.38 | |
P value | 0.23 | 0.23 | 0.17 | 1.00 | 0.23 | 1.00 |
∗Luteinizing hormone; ∗∗follicle-stimulating hormone; ∗∗∗free thyroxin; ∗∗∗∗thyroid-stimulating hormone.